Your browser doesn't support javascript.
loading
Clinically significant CYP2C inhibition by noscapine but not by glucosamine.
Rosenborg, S; Stenberg, M; Otto, S; Ostervall, J; Masquelier, M; Yue, Q-Y; Bertilsson, L; Eliasson, E.
Afiliación
  • Rosenborg S; Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, Stockholm, Sweden. staffan.rosenborg@ki.se
Clin Pharmacol Ther ; 88(3): 343-6, 2010 Sep.
Article en En | MEDLINE | ID: mdl-20668444
ABSTRACT
Noscapine and glucosamine reportedly interact with warfarin. We investigated the effects of these drugs on various cytochrome P450 (CYP) activity markers. Twelve healthy subjects were phenotyped at baseline and during separate treatments with noscapine and glucosamine. Whereas glucosamine had no significant effect on CYP activity, noscapine caused marked inhibition of CYP2C9 (4.9-fold increase in urinary losartan/E3174 ratio) and CYP2C19 (3.6-fold increase in the plasma omeprazole/5-hydroxyomeprazole ratio). Noscapine-dependent inhibition of CYP2C9 may explain the interaction with warfarin.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hidrocarburo de Aril Hidroxilasas / Glucosamina / Noscapina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2010 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hidrocarburo de Aril Hidroxilasas / Glucosamina / Noscapina Tipo de estudio: Clinical_trials Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Pharmacol Ther Año: 2010 Tipo del documento: Article País de afiliación: Suecia